Xencor, Inc.
Modulation of T cells with bispecific antibodies and Fc fusions
Last updated:
Abstract:
The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
Status:
Grant
Type:
Utility
Filling date:
8 Mar 2019
Issue date:
17 Aug 2021